12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks showed significant movement. Qilian Intl Hldg Gr (QLI) led the gainers with a 73.2% increase, while Vivos Therapeutics (VVOS) experienced the largest drop among the losers, falling 12.6%. Notably, Dare Bioscience (DARE), Vivos Therapeutics (VVOS), and Pulse Biosciences (PLSE) released their Q4 earnings reports, influencing their stock movements.
March 28, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pulse Biosciences stock decreased by 11.37% to $7.72 after their Q4 earnings, with a market cap of $425.2 million.
The drop in PLSE stock price post-earnings indicates a negative market reaction to their Q4 financial performance.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Vivos Therapeutics stock fell 12.6% after the release of their Q4 earnings report, with a market value of $5.6 million.
The decline in VVOS stock price post-earnings suggests the market reacted negatively to their Q4 financial performance.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Dare Bioscience stock rose 12.19% to $0.55 after their Q4 earnings report, with a market cap of $54.2 million.
The increase in DARE's stock price following their earnings report suggests a favorable investor response to their financial results.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Qilian Intl Hldg Gr shares surged 73.2% in after-market trading, with a market cap of $39.3 million.
The substantial increase in QLI's stock price indicates strong investor interest, potentially due to positive market sentiment or speculative trading.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90